Search

Your search keyword '"Follath, Ferenc"' showing total 426 results
Start Over Author "Follath, Ferenc"
426 results on '"Follath, Ferenc"'

1. Clinical Outcomes According to ECG Presentations in Infarct-Related Cardiogenic Shock in the Culprit Lesion Only PCI vs Multivessel PCI in Cardiogenic Shock Trial

Author

Thiele, Holger, Desch, Steffen, Zeymer, Uwe, Montalescot, Gilles, Piek, Jan J., Torremante, Patrizia, Meyer-Saraei, Roza, Tebbe, Ulrich, Wöhrle, Jochen, Pachinger, Otmar, Busch, Clemens, Pfeiffer, Nathalie, Neumer, Alexander, Schneider, Steffen, Ouarrak, Taoufik, Reimer, Thomas, Lober, Christiane, Clemmensen, Peter, Follath, Ferenc, Wegscheider, Karl, Barthélémy, O., Zeitouni, M., Overtchouk, P., Guedeney, P., Hage, G., Hauguel-Moreau, Zeitouni, Michel, Akin, Ibrahim, Barthélémy, Olivier, Brugier, Delphine, Collet, Jean-Philippe, de Waha-Thiele, Suzanne, Greenwood, John P., Guedeney, Paul, Hage, Georges, Hauguel-Moreau, Marie, Huber, Kurt, Kerneis, Mathieu, Noc, Marko, Oldroyd, Keith G., Rouanet, Stéphanie, Savonitto, Stefano, Serpytis, Pranas, Silvain, Johanne, Stepinska, Janina, Vicaut, Eric, Vrints, Christiaan J.M., and Windecker, Stephan

Published
2021
Full Text
View/download PDF

3. Levosimendan: Molecular mechanisms and clinical implications: Consensus of experts on the mechanisms of action of levosimendan

Author

Papp, Zoltán, Édes, István, Fruhwald, Sonja, De Hert, Stefan G., Salmenperä, Markku, Leppikangas, Heli, Mebazaa, Alexandre, Landoni, Giovanni, Grossini, Elena, Caimmi, Philippe, Morelli, Andrea, Guarracino, Fabio, Schwinger, Robert H.G., Meyer, Sven, Algotsson, Lars, Wikström, Bernt Gerhard, Jörgensen, Kirsten, Filippatos, Gerasimos, Parissis, John T., González, Martín J. García, Parkhomenko, Alexander, Yilmaz, Mehmet Birhan, Kivikko, Matti, Pollesello, Piero, and Follath, Ferenc

Published
2012
Full Text
View/download PDF

6. Differences in clinical characteristics, management and short-term outcome between acute heart failure patients chronic obstructive pulmonary disease and those without this co-morbidity

Author

Parissis, John T., Andreoli, Chiara, Kadoglou, Nikolaos, Ikonomidis, Ignatios, Farmakis, Dimitrios, Dimopoulou, Ioanna, Iliodromitis, Efstathios, Anastasiou-Nana, Maria, Lainscak, Mitja, Ambrosio, Giussepe, Mebazaa, Alexandre, Filippatos, Gerasimos, and Follath, Ferenc

Published
2014
Full Text
View/download PDF

12. Bisoprolol vs. carvedilol in elderly patients with heart failure: rationale and design of the CIBIS-ELD trial

Author

Düngen, Hans-Dirk, Apostolović, Svetlana, Inkrot, Simone, Tahirović, Elvis, Krackhardt, Florian, Pavlović, Milan, Putniković, Biljana, Lainščak, Mitja, Gelbrich, Götz, Edelmann, Frank, Wachter, Rolf, Eschenhagen, Thomas, Waagstein, Finn, Follath, Ferenc, Rauchhaus, Mathias, Haverkamp, Wilhelm, Osterziel, Karl-Josef, Dietz, Rainer, and on behalf of the CIBIS-ELD investigators, subproject “Multicenter Trials” in the Competence Network Heart Failure

Published
2008
Full Text
View/download PDF

15. Effects of metabolites and analogs of amiodarone on alveolar macrophages: structure-activity relationship

Author

Quaglino, Daniela, Ha, Huy Riem, Duner, Elena, Bruttomesso, Daniela, Bigler, Laurent, Follath, Ferenc, Realdi, Giuseppe, Pettenazzo, Andrea, and Baritussio, Aldo

Subjects
Amiodarone -- Research, Biological sciences
Abstract

Amiodarone, an antiarrhythmic drug toxic toward the lung, is metabolized through sequential modifications of the diethylaminoethoxy group to mono-N-desethylamiodarone (MDEA), di-N-desethylamiodarone (DDEA), and amiodarone-EtOH (B2-O-EtOH), whose effects on lung cells are unclear. To clarify this, we exposed rabbit alveolar macrophages to analogs with different modifications of the diethylaminoethoxy group and then searched for biochemical signs of cell damage, formation of vacuoles and inclusion bodies, and interference with the degradation of surfactant protein A, used as a tracer of the endocytic pathway. The substances studied included MDEA, DDEA, and B2-O-EtOH, analogs with different modifications of the diethylaminoethoxy group, fragments of the amiodarone molecule, and the antiarrhythmic agents dronedarone (SR-33589) and KB-130015. We found the following: 1) MDEA, DDEA, and B2-O-EtOH rank in order of decreasing toxicity toward alveolar macrophages, indicating that dealkylation and deamination of the diethylaminoethoxy group represent important mechanisms of detoxification; 2) dronedarone has greater, and KB-130015 has smaller, toxicity than amiodarone toward alveolar macrophages; and 3) the benzofuran moiety, which is toxic to liver cells, is not directly toxic toward alveolar macrophages. dronedarone; KB-130015

Published
2004

23. Improved survival with bisoprolol in patients with heart failure and renal impairment: an analysis of the cardiac insufficiency bisoprolol study II (CIBIS-II) trial

Author

Castagno, Davide, Jhund, Pardeep S., McMurray, John J.V., Lewsey, James D., Erdmann, Erland, Zannad, Faiez, Remme, Willem J., Lopez-Sendon, José L., Lechat, Philippe, Follath, Ferenc, Höglund, Christer, Mareev, Viacheslav, Sadowski, Zygmunt, Seabra-Gomes, Ricardo J., and Dargie, Henry J.

Published
2010
Full Text
View/download PDF

24. Assessing and grading congestion in acute heart failure: a scientific statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine

Author

Gheorghiade, Mihai, Follath, Ferenc, Ponikowski, Piotr, Barsuk, Jeffrey H., Blair, John E.A., Cleland, John G., Dickstein, Kenneth, Drazner, Mark H., Fonarow, Gregg C., Jaarsma, Tiny, Jondeau, Guillaume, Sendon, Jose Lopez, Mebazaa, Alexander, Metra, Marco, Nieminen, Markku, Pang, Peter S., Seferovic, Petar, Stevenson, Lynne W., van Veldhuisen, Dirk J., Zannad, Faiez, Anker, Stefan D., Rhodes, Andrew, McMurray, John J.V., and Filippatos, Gerasimos

Published
2010
Full Text
View/download PDF

29. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)

Author

Dickstein, Kenneth, Cohen-Solal, Alain, Filippatos, Gerasimos, McMurray, John J.V., Ponikowski, Piotr, Poole-Wilson, Philip Alexander, Strömberg, Anna, van Veldhuisen, Dirk J., Atar, Dan, Hoes, Arno W., Keren, Andre, Mebazaa, Alexandre, Nieminen, Markku, Priori, Silvia Giuliana, Swedberg, Karl, Vahanian, Alec, Camm, John, De Caterina, Raffaele, Dean, Veronica, Dickstein, Kenneth, Funck-Brentano, Christian, Hellemans, Irene, Kristensen, Steen Dalby, McGregor, Keith, Sechtem, Udo, Silber, Sigmund, Tendera, Michal, Widimsky, Petr, Zamorano, Jose Luis, Tendera, Michal, Auricchio, Angelo, Bax, Jeroen, Böhm, Michael, Corrà, Ugo, della Bella, Paolo, Elliott, Perry M., Follath, Ferenc, Gheorghiade, Mihai, Hasin, Yonathan, Hernborg, Anders, Jaarsma, Tiny, Komajda, Michel, Kornowski, Ran, Piepoli, Massimo, Prendergast, Bernard, Tavazzi, Luigi, Vachiery, Jean-Luc, Verheugt, Freek W. A., and Zannad, Faiez

Published
2008

50. Relation of the level of high-density lipoprotein subfractions to the presence and extent of coronary artery disease

Author

Drexel, Heinz, Amann, Franz W., Rentsch, Katharina, Neuenschwander, Christian, Leuthy, Antonia, Khan, Shabana I., and Follath, Ferenc

Subjects
High density lipoproteins -- Physiological aspects, Coronary heart disease -- Risk factors, Blood cholesterol -- Physiological aspects, Health
Abstract

Plasma lipid profiles, including high-density lipoprotein (HDL) subfractions [HDL. sub. 2] and [HDL. sub. 3], were obtained in 115 men undergoing coronary angiography to assess the relation of lipid levels to coronary artery disease (CAD). CAD was present in 87 patients (76%) and absent in 28 (24%). The largest difference between the 2 groups was observed for [HDL. sub. 2] cholesterol, with a mean of 0.13 mmol/liter (5 mg/dl) in patients with CAD compared with 0.25 mmol/liter (10 mg/dl) in those without CAD (p

Published
1992

Catalog

Books, media, physical & digital resources
See catalog results